Monalizumab and MEDI5752 in Patients With MSI and/or dMMR Metastatic Cancer

NCT06152523 · clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
OTHER
Sponsor class

Stopped The study has been halted because the manufacturer can no longer supply the experimental treatment

Conditions

Interventions

Sponsor

Assistance Publique - Hôpitaux de Paris